Literature DB >> 7023312

Inappropriate secretion of thyroid-stimulating hormone.

.   

Abstract

Recent studies have provided major new insights into the syndromes of inappropriate secretion of thyroid-stimulating hormone (TSH), a heterogeneous group of disorders in which patients show inappropriately elevated levels of serum immunoactive TSH in the presence of elevated free thyroid hormone levels. Certain of these patients appear to have a non-neoplastic disorder associated with variable degrees of pituitary and peripheral resistance to the action of thyroid hormone, whereas others harbor a tumor of pituitary thyrotropic cells. Measurement of free serum alpha subunit has proved valuable in differentiating these disorders, showing normal alpha concentration and alpha-to-TSH ratios in the non-neoplastic and highly elevated values in the neoplastic disorders. All these syndromes appear unrelated to Graves' disease because thyroid-binding and thyroid-stimulating antibodies are usually absent. Some of these patients also have abnormal metabolism of thyroid hormones. Although the pathogenesis of these syndromes remains to be elucidated, increased recognition and study of these patients should provide fundamental insights into the regulation of TSH secretion as well as the action of thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7023312     DOI: 10.7326/0003-4819-95-3-339

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Clinical hyperthyroidism due to non-neoplastic inappropriate thyrotrophin secretion.

Authors:  A W Chan; I A MacFarlane; C van Heyningen; P M Foy
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

2.  Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.

Authors:  J L Jameson; A Klibanski; P M Black; N T Zervas; C M Lindell; D W Hsu; E C Ridgway; J F Habener
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene.

Authors:  M P McDonald; R Wong; G Goldstein; B Weintraub; S Y Cheng; J N Crawley
Journal:  Learn Mem       Date:  1998 Sep-Oct       Impact factor: 2.460

4.  Hyperthyroidism due to a thyrotropin secreting pituitary adenoma.

Authors:  J P McCann; J K Nelson
Journal:  Ir J Med Sci       Date:  1985-09       Impact factor: 1.568

5.  Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta.

Authors:  A Sakurai; K Takeda; K Ain; P Ceccarelli; A Nakai; S Seino; G I Bell; S Refetoff; L J DeGroot
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 6.  The syndromes of reduced sensitivity to thyroid hormone.

Authors:  Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Biochim Biophys Acta       Date:  2012-08-16

7.  Shrinkage of thyrotrophin secreting pituitary adenoma treated with octreotide.

Authors:  S M Orme; J T Lamb; M Nelson; P E Belchetz
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

8.  A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene.

Authors:  G Medeiros-Neto; D T Herodotou; S Rajan; S Kommareddi; L de Lacerda; R Sandrini; M C Boguszewski; A N Hollenberg; S Radovick; F E Wondisford
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

9.  Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families.

Authors:  R E Weiss; M Weinberg; S Refetoff
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

Review 10.  Hyperthyroidism. Current drug therapy.

Authors:  J R Stockigt; D J Topliss
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.